A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia
Public ClinicalTrials.gov record NCT00977522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2, Double-Blind, Placebo-Controlled, Multi-Center Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia Treated With A Stable Dose Of A Second Generation Antipsychotic
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is examining the efficacy of PF-03463275 compared to placebo in treating negative symptoms of schizophrenia when added to ongoing antipsychotic treatment in stable outpatients with schizophrenia.
Study identification
- NCT ID
- NCT00977522
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2009 (Type not available)
- Primary completion
- Sep 2010 (Actual)
- Completion
- Sep 2010 (Actual)
- Last update posted
- Feb 7, 2012
2009 – 2010
United States locations
- U.S. sites
- 37
- U.S. states
- 13
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Cerritos | California | 90703 | — |
| Pfizer Investigational Site | Chula Vista | California | 91910 | — |
| Pfizer Investigational Site | Escondido | California | 92025 | — |
| Pfizer Investigational Site | Garden Grove | California | 92845 | — |
| Pfizer Investigational Site | Glendale | California | 91436 | — |
| Pfizer Investigational Site | Long Beach | California | 90805 | — |
| Pfizer Investigational Site | Long Beach | California | 90808 | — |
| Pfizer Investigational Site | National City | California | 91950 | — |
| Pfizer Investigational Site | Paramount | California | 90723 | — |
| Pfizer Investigational Site | Torrance | California | 90502 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20016 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20036 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30308 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30328 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30333 | — |
| Pfizer Investigational Site | Park Ridge | Illinois | 60068 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67207 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67211 | — |
| Pfizer Investigational Site | Flowood | Mississippi | 39232 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89102 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89128 | — |
| Pfizer Investigational Site | Runnemede | New Jersey | 08078 | — |
| Pfizer Investigational Site | Toms River | New Jersey | 08755 | — |
| Pfizer Investigational Site | Willingboro | New Jersey | 08046 | — |
| Pfizer Investigational Site | Fresh Meadows | New York | 11366 | — |
| Pfizer Investigational Site | Holliswood | New York | 11423 | — |
| Pfizer Investigational Site | Staten Island | New York | 10304 | — |
| Pfizer Investigational Site | Staten Island | New York | 10305 | — |
| Pfizer Investigational Site | Edmond | Oklahoma | 73034 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73116 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19139 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38119 | — |
| Pfizer Investigational Site | Austin | Texas | 78731 | — |
| Pfizer Investigational Site | Austin | Texas | 78754 | — |
| Pfizer Investigational Site | Bellaire | Texas | 77401 | — |
| Pfizer Investigational Site | Houston | Texas | 77008 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00977522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2012 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00977522 live on ClinicalTrials.gov.